• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-2019 大流行期间急性缺血性脑卒中血管内治疗的管理:中国多中心调查。

Management of endovascular therapy for acute ischemic stroke amid the COVID-2019 pandemic: a multicenter survey in China.

机构信息

Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

China National Clinical Research Center for Neurological Diseases, Beijing, China.

出版信息

Neurol Res. 2021 Oct;43(10):823-830. doi: 10.1080/01616412.2021.1939236. Epub 2021 Aug 10.

DOI:10.1080/01616412.2021.1939236
PMID:34375569
Abstract

: The impact of COVID-19 pandemic on endovascular therapy (EVT) for acute ischemic stroke in China is unknown. This study was aimed to verify the volume change of EVT for acute ischemic stroke affected by COVID-19 and its potential factors. This cross-sectional study was conducted via an online questionnaire survey in China. The questionnaire was mainly composed of descriptive information, volume change of EVT for acute ischemic stroke, and the protection status of medical staff. A total of 103 stroke physicians in 28 provinces across China completed the survey questionnaire. A volume decline in EVT for acute stroke occurred in 93 (90.3%) hospitals after lockdown (23 January 2020). Nearly half of the hospitals (51/103, 49.5%) experienced a volume decline of EVT case more than 50% and 14 (13.6%) hospitals completely ceased offering EVT. Hospitals with decline >50% of EVT case had higher proportion of hospitals with a designated area for COVID-19 screening in the emergency room (44/51, 86.3% vs 34/52, 65.4%, = 0.01) and medical staff in quarantine (19/51, 37.3% vs 7/52, 13.5%, < 0.01), with lower proportion of hospitals with personal protective equipment protocol (41/51, 80.4% vs 49/52, 94.2%, = 0.03) than hospitals with decline ≤50%. The volume of EVT for acute ischemic stroke severely declined after lockdown in China. Designating a specific area for COVID-19 screening, insufficient personal protection and understaffing may exacerbate the volume decline of EVT.

摘要

:COVID-19 大流行对中国急性缺血性脑卒中血管内治疗(EVT)的影响尚不清楚。本研究旨在验证 COVID-19 对急性缺血性脑卒中 EVT 数量的影响及其潜在因素。这是一项在中国进行的横断面研究,通过在线问卷调查进行。问卷主要由描述性信息、急性缺血性脑卒中 EVT 数量变化和医务人员保护状况组成。共有来自中国 28 个省的 103 名脑卒中医生完成了问卷调查。封锁后(2020 年 1 月 23 日),93 家(90.3%)医院的急性脑卒中 EVT 数量下降。近一半的医院(51/103,49.5%)EVT 病例数量下降超过 50%,14 家(13.6%)医院完全停止提供 EVT。EVT 病例数量下降超过 50%的医院,其急诊科有专门用于 COVID-19 筛查的区域的医院比例更高(44/51,86.3%比 34/52,65.4%,=0.01),处于隔离状态的医务人员比例也更高(19/51,37.3%比 7/52,13.5%,<0.01),而个人防护设备方案的医院比例更低(41/51,80.4%比 49/52,94.2%,=0.03)。中国封锁后,急性缺血性脑卒中 EVT 的数量严重下降。专门为 COVID-19 筛查划定特定区域、个人防护不足和人员配备不足可能会加剧 EVT 数量的下降。

相似文献

1
Management of endovascular therapy for acute ischemic stroke amid the COVID-2019 pandemic: a multicenter survey in China.COVID-2019 大流行期间急性缺血性脑卒中血管内治疗的管理:中国多中心调查。
Neurol Res. 2021 Oct;43(10):823-830. doi: 10.1080/01616412.2021.1939236. Epub 2021 Aug 10.
2
Management of Acute Ischemic Stroke in the Interventional Neuroradiology Suite During the COVID-19 Pandemic: A Global Survey.COVID-19 大流行期间介入神经放射学套房中急性缺血性脑卒中的管理:全球调查。
J Neurosurg Anesthesiol. 2021 Jan;33(1):44-50. doi: 10.1097/ANA.0000000000000734.
3
Influence of Guidelines in Endovascular Therapy Decision Making in Acute Ischemic Stroke: Insights From UNMASK EVT.急性缺血性脑卒中血管内治疗决策中指南的影响:UNMASK EVT 的见解。
Stroke. 2019 Dec;50(12):3578-3584. doi: 10.1161/STROKEAHA.119.026982. Epub 2019 Nov 5.
4
Acute Stroke Management During the COVID-19 Pandemic: Does Confinement Impact Eligibility for Endovascular Therapy?新冠疫情期间的急性脑卒中管理:隔离是否影响血管内治疗的适应证?
Stroke. 2020 Aug;51(8):2593-2596. doi: 10.1161/STROKEAHA.120.030794. Epub 2020 Jul 1.
5
Management of Endovascular Treatment for Acute Ischemic Stroke During the COVID-19 Pandemic at a Single Institution in Beijing, China: A Brief Report.中国北京某单一机构在新冠疫情期间急性缺血性卒中血管内治疗的管理:简要报告
J Neurosurg Anesthesiol. 2021 Jul 1;33(3):268-272. doi: 10.1097/ANA.0000000000000748.
6
Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry.基于全国前瞻性登记研究的急性基底动脉闭塞血管内治疗评估。
JAMA Neurol. 2020 May 1;77(5):561-573. doi: 10.1001/jamaneurol.2020.0156.
7
Factors Associated With the Decision-Making on Endovascular Thrombectomy for the Management of Acute Ischemic Stroke.影响急性缺血性脑卒中血管内取栓治疗决策的因素。
Stroke. 2019 Sep;50(9):2441-2447. doi: 10.1161/STROKEAHA.119.025631. Epub 2019 Jul 22.
8
Routing to Endovascular Treatment of Ischemic Stroke in Korea: Recognition of Need for Process Improvement.韩国缺血性脑卒中血管内治疗的转归:认识到需要改进流程。
J Korean Med Sci. 2020 Oct 26;35(41):e347. doi: 10.3346/jkms.2020.35.e347.
9
Decline and Recurrence of Stroke Consultations during the COVID-19 Pandemic Lockdown Parallels Population Activity Levels.在 COVID-19 大流行封锁期间,中风咨询量下降和复发与人群活动水平平行。
Cerebrovasc Dis. 2021;50(3):317-325. doi: 10.1159/000514154. Epub 2021 Feb 4.
10
Early Infarct Growth Rate Correlation With Endovascular Thrombectomy Clinical Outcomes: Analysis From the SELECT Study.早期梗死增长率与血管内血栓切除术临床结局的相关性:SELECT 研究分析。
Stroke. 2021 Jan;52(1):57-69. doi: 10.1161/STROKEAHA.120.030912. Epub 2020 Dec 7.